首页> 美国卫生研究院文献>other >Demonstrating the Value of an ACL Registry
【2h】

Demonstrating the Value of an ACL Registry

机译:展示ACL注册中心的价值

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Objectives:One purpose of a registry is to identify procedures or devices that have either good or poor outcomes and improve treatment outcomes through feedback to surgeons. In 2010 we initially reported the influence of graft choice on the risk of early revision after ACL Reconstruction (ACLR). In 2012 we reported a three times higher risk of revision if allograft was used rather than bone-patellar tendon-bone (BPTB) autograft. In subsequent studies of allografts, we have identified poorer results with BPTB allografts compared to soft tissue allografts and with soft tissue allografts irradiated with > 1.8 Mrads or processed with chemical methods. Patients < 21 years of age were also identified to be at particularly high-risk for revision if allograft tissue was employed. These registry findings were disseminated to surgeons within and outside our integrated healthcare system. The purpose of this study was to evaluate the impact of registry feedback on surgeon graft type selection.
机译:目标:注册管理机构的一个目的是确定具有良好或不良结果的程序或设备,并通过反馈给外科医生来改善治疗效果。在2010年,我们最初报道了移植物选择对ACL重建(ACLR)后早期翻修风险的影响。在2012年,我们报道如果使用同种异体移植而不是bone骨肌腱-骨(BPTB)自体移植,则翻修风险高三倍。在随后的同种异体移植研究中,我们发现与软组织同种异体移植物以及用> 1.8 Mrads辐照或用化学方法处理的同种异体软组织移植物相比,BPTB同种异体移植物的结果较差。如果采用同种异体移植组织,<21岁的患者也被认为特别容易发生翻修。这些注册表结果已分发给我们集成医疗系统内外的外科医生。这项研究的目的是评估注册表反馈对外科医生移植物类型选择的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号